Press release
Cancer Biopsy Market to Command US$ 131.4 Billion Backed by Soaring 18% CAGR Growth By the end of 2033
Cancer Biopsy Market
The increasing elderly populace, along with the rise in cancer diagnoses, is fueling growth in the cancer clinical market. Also, the practical and less costly use of liquid biopsy procedures and increasing biopsy appointees are all expected to impact the market growth.
Some of today's prominent procedures in medical diagnosis include endoscopic, arthroscopic, bone marrow, skin, needle, and surgical biopsies. Needle biopsies are regarded as a trusted method for the early detection of patients suffering from these methods. However, fine-needle aspiration needle biopsies, which are less invasive and faster, are aiding the increase in popularity of the slice.
Unlock the Treasures of Knowledge with our PDF Samples.@
https://www.futuremarketinsights.com/reports/sample/rep-gb-16508
The IARC estimates that by 2020 the worldwide burden of disease due to cancer is projected to be 19.3 million cases and 9.96 million deaths worldwide. A liquid biopsy entails reduced expense, earlier prognosis, therapy surveillance, identification of tumor heterogeneity, acquired drug resistance, and patient comfort compared to conventional diagnostic tools for handling cancer.
Competitive Analysis
Key companies are helping to drive market expansion by diversifying their diagnostics portfolios and increasing the adoption of their biopsy tools.
Key recent developments of key players in the Cancer Biopsy Market are as follows:
-In March 2021, in Russia, KIllumina, Inc. received medical device approval for their NextSeq 550Dx platform and related reagent kits. Before this registration, the MiSeq Dx had already been approved as a medical device.
-In March 2021, Autopsy with Quick-Core IZI Medical Products introduced a system for soft tissue biopsy procedures. This fully automated product is based on Quick-Core, the company's patented semi-automatic method.
Competitive Landscape
Key companies are helping to drive market expansion by diversifying their diagnostics portfolios and increasing the adoption of their biopsy tools.
-In March 2021, In Russia, KIllumina, Inc. received medical device approval for their NextSeq 550Dx platform and related reagent kits. Before this registration, the MiSeq Dx had already been approved as a medical device.
-In March 2021, Autopsy with Quick-Core IZI Medical Products introduced a system for soft tissue biopsy procedures. This fully automated product is based on Quick-Core, the company's patented semi-automatic method.
-In April 2021, Plasma-SeqSensei liquid biopsy research use-only (RUO) kits were introduced in EMEA by Sysmex Europe GmbH and Sysmex Inostics GmbH.
Witness the transformation brought by our methodology insights today. @
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-16508
More Insights Available
Future Market Insights, in its new offering, presents an unbiased analysis of the Cancer Biopsy Market, presenting historical market data (2018-2022) and forecast statistics for the period of 2023-2033.
The study reveals essential insights based on Type (Tissue Biopsies, Liquid biopsies, Other Types), Product Type (Instruments, Kits, Consumables, Services), Application (Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Prostate Cancers, Skin Cancers, Blood Cancers, Kidney Cancers, Liver Cancers, Pancreatic Cancers, Ovarian Cancers, Other Applications) across five regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa).
Market Segments Covered in Cancer Biopsy Industry Analysis
By Type:
-Tissue Biopsies
--Needle Biopsies
--Surgical Biopsies
-Liquid Biopsies
-Other Types
By Product Type:
-Instruments
-Kits and Consumables
-Services
By Application:
-Breast Cancer
-Colorectal Cancer
-Cervical Cancers
-Lung Cancers
-Prostate Cancers
-Skin Cancers
-Blood Cancers
-Kidney Cancers
-Liver Cancers
-Pancreatic Cancers
-Ovarian Cancers
-Other Applications
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Access Full Report, Act Informed: @
https://www.futuremarketinsights.com/reports/cancer-biopsy-market
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel, and End Use over the next 10 years.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Biopsy Market to Command US$ 131.4 Billion Backed by Soaring 18% CAGR Growth By the end of 2033 here
News-ID: 3184913 • Views: …
More Releases from Future Market Insights Inc.
Global Aerographite Market Outlook 2036: Growth, Regional Leaders & Key Players …
According to the latest analysis by Future Market Insights, the global aerographite market is entering a pivotal phase of industrial relevance, transitioning from niche nanomaterial curiosity to a commercially viable solution for weight-sensitive, high-performance applications. With aerospace OEMs, satellite integrators, and advanced energy system designers seeking materials that deliver structural strength without mass penalties, aerographite is emerging as a compelling answer. The convergence of scalable production methods and expanding end-use…
Global Textile-Based pH Controllers Market Set to Hit USD 2.50 Billion by 2036 | …
According to the latest analysis by Future Market Insights, in an industry where margins are tight and environmental scrutiny is rising, seemingly minor process variables are becoming boardroom priorities. One such variable-pH control in textile wet processing-is quietly reshaping operational efficiency, compliance strategies, and supplier dynamics. The global textile-based pH controllers market, once considered a niche within auxiliary chemicals, is now evolving into a critical enabler of quality assurance, cost…
Bio-Ceramics and Hydroxyapatite Market Enters a Clinical Expansion Phase as Inno …
According to the latest analysis by Future Market Insights, the global bio-ceramics and hydroxyapatite market is moving beyond its traditional role as a niche materials segment into a clinically strategic pillar of modern healthcare. With applications expanding from orthopaedic implants to regenerative medicine and drug delivery, the sector is entering a decade defined less by incremental demand and more by technological and regulatory inflection points. For executives and investors, the…
Bioethanol Market Enters Policy-Driven Expansion Cycle as Energy Security and De …
According to the latest analysis by Future Market Insights, the global bioethanol market is shifting from a cyclical, commodity-driven industry into a structurally supported pillar of national energy and climate strategies. What was once a blending option is now a compliance requirement. Governments across major economies are tightening renewable fuel mandates, and fuel distributors are responding by embedding bioethanol procurement into long-term supply strategies. This transition is reshaping capital allocation,…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
